Injection-site reactions Community reports cluster around mild redness or itching at the subcutaneous injection site, typically lasting under 24 hours
In dermatology and trichology research, it is often combined with other copper-binding or Wnt-active peptides as a single topical formulation
One study utilized chitosan nanoparticles, a biocompatible and biodegradable polymer, as a carrier for doxorubicin and AOD 9604
The most common are 5 mg, 10 mg, 15 mg, 30 mg, and 60 mg
doi:10.1007/s13760-015-0427-y Ernst E, Pittler MH
Table 4 Therapeutic controversies over use of vitamin D supplement during cancer treatment